NI’s B-Secur raises US$12million to accelerate heart health technology

Belfast company extends its global presence after securing US investment for first time
Watch more of our videos on Shots! 
and live on Freeview channel 276
Visit Shots! now

Belfast ECG technology company, B-Secur has announced that it has raised £8.8million (US$12million) in 2021 including, for the first time, funding from a U.S. investor.

This investment, which is a sign of the company’s global intent, will be used to further develop key technology and accelerate B-Secur’s commercial expansion within the United States in the Consumer and Medical industries.

Hide Ad
Hide Ad

The announcement comes as B-Secur recently welcomed around 30 stakeholders locally as well as from the U.S. and across the UK to its Belfast headquarters at Catalyst.

B-Secur CEO, Alan Foreman and First Capital Ventures executive managing director, Gary Graham during his recent visit to B-Secur’s Belfast headquarters at CatalystB-Secur CEO, Alan Foreman and First Capital Ventures executive managing director, Gary Graham during his recent visit to B-Secur’s Belfast headquarters at Catalyst
B-Secur CEO, Alan Foreman and First Capital Ventures executive managing director, Gary Graham during his recent visit to B-Secur’s Belfast headquarters at Catalyst

The event was an opportunity for investors to meet the B-Secur team in person, many for the first time given the pandemic, along with the company’s board members and shareholders, learn about its future plans and see its latest technology in a Covid-safe environment.

The £8.8million was raised over several follow-on financing rounds throughout 2021 which included existing UK-based investors Wharton Asset Management, Kernel Capital and Co-Fund NI (managed by Clarendon Fund Managers) plus first-time US investment into B-Secur from Denver-based First Capital Ventures.

The finance will also support the further development of the company’s flagship ECG technology, the FDA-cleared HeartKey® algorithms to be integrated into consumer devices and medical devices within the growing managed care and remote patient monitoring industry.

Hide Ad
Hide Ad

In response B-Secur co-founder and CEO, Alan Foreman said the investment from First Capital Ventures marked a significant development for the Belfast company.

He continued: “We are delighted to welcome First Capital Ventures as our latest and first U.S. investor alongside the continued commitment from our existing investor base.

“Having received FDA clearance for our HeartKey® ECG technology earlier this year, we’ve been working to grow our existing base in Belfast with more highly skilled people and to establish a stronger presence in the U.S.

“This investment is a strong testimony to our cutting-edge ECG technology and B-Secur’s global scalability.”

Hide Ad
Hide Ad

First Capital Ventures invests in innovative technologies that disrupt industries. Its portfolio includes rising startups such as SOBRsafe and eSports Entertainment Group which was recently listed on Nasdaq.

“We seek investment opportunities that make the world a better place and positively impact peoples’ lives,” said Gary Graham, executive managing director at First Capital Ventures.

“At First Capital Ventures we have no doubt that the ground-breaking work B-Secur is doing has the power to be truly transformative.

“We are looking forward to a joint contribution and the benefit of uniquely combining B-Secur’s attributes with ours – both intellectually and economically.”

Hide Ad
Hide Ad

Founded in Belfast, B-Secur are on a mission to revolutionise the way people experience technology in the connected world using their unique heartbeat.

In addition to the recent investment announcement, B-Secur has also revealed that its expanding U.S. team will be bolstered by three newly appointed executives.

Dr. David Steinhaus, former medical director and vice president at Medtronic for 14 years joins B-Secur’s senior management team as Americas Advisor to the Board.

B-Secur has also appointed University of Utah’s Assistant Professor Benjamin Sanchez as Scientific Advisor to the Board and Sean Fallon as VP of U.S. Sales.

Hide Ad
Hide Ad

The key appointments come as B-Secur, which already employs over 50 scientists and engineers, is in the midst of a recruitment drive as it seeks to expand its team at its Belfast headquarters and in the U.S.

A message from the Editor:

Thank you for reading this story on our website. While I have your attention, I also have an important request to make of you.

In order for us to continue to provide high quality and trusted local news on this free-to-read site, I am asking you to also please purchase a copy of our newspaper whenever you are able to do so.

Our journalists are highly trained and our content is independently regulated by IPSO to some of the most rigorous standards in the world. But being your eyes and ears comes at a price. So we need your support more than ever to buy our newspapers during this crisis.

Hide Ad
Hide Ad

With the coronavirus lockdown having a major impact on many of our local valued advertisers - and consequently the advertising that we receive - we are more reliant than ever on you helping us to provide you with news and information by buying a copy of our newspaper when you can safely.

You can also enjoy unlimited access to the best news from across Northern Ireland and the UK by subscribing to newsletter.co.uk

With a digital subscription, you can read more than five articles, see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content. Visit https://www.newsletter.co.uk/subscriptions now to sign up.

Thank you

Related topics: